In late osteoblasts and osteocytes, FGF23 can be upregulated by elevated phosphate, anemia, inflammation, PTH and 1,25D; and downregulated by hypophosphatemia, insulin, and insulin-like growth factor 1. Here, IGF1 is linked to hypophosphatemia.